| Nome |
# |
|
Medicinal Chemistry, Pharmacology, and Clinical Implications of TRPV1 Receptor Antagonists, file e309ade4-04d5-3969-e053-3a05fe0a2c94
|
639
|
|
The A3 adenosine receptor: history and perspectives, file e309ade2-c090-3969-e053-3a05fe0a2c94
|
634
|
|
A3 Adenosine Receptors as Modulators of Inflammation: From Medicinal Chemistry to Therapy, file e309ade2-c09e-3969-e053-3a05fe0a2c94
|
200
|
|
Adenosine as a Multi-Signalling Guardian Angel in Human Diseases: When, Where and How Does it Exert its Protective Effects?, file e309ade3-ab46-3969-e053-3a05fe0a2c94
|
182
|
|
Targeting A3 and A2A adenosine receptors in the fight against cancer, file e309ade3-9ab5-3969-e053-3a05fe0a2c94
|
124
|
|
Pulsed electromagnetic field and relief of hypoxia-induced neuronal cell death: The signaling pathway, file e309ade4-2758-3969-e053-3a05fe0a2c94
|
115
|
|
Pulsed Electromagnetic Field Exposure Reduces Hypoxia and Inflammation Damage in Neuron-Like and Microglial Cells, file e309ade4-3d6d-3969-e053-3a05fe0a2c94
|
111
|
|
Pharmacology of Adenosine Receptors: The State of the Art, file e309ade1-e760-3969-e053-3a05fe0a2c94
|
88
|
|
Inhibition of A2A Adenosine Receptor Signaling in Cancer Cells Proliferation by the Novel Antagonist TP455, file e309ade1-8c14-3969-e053-3a05fe0a2c94
|
75
|
|
Antioxidant and antiinflammatory effects of epilobium parviflorum, melilotus officinalis and cardiospermum halicacabum plant extracts in macrophage and microglial cells, file e309ade5-304d-3969-e053-3a05fe0a2c94
|
70
|
|
A(2B) adenosine receptors stimulate IL-6 production in primary murine microglia through p38 MAPK kinase pathway, file e309ade3-a9ed-3969-e053-3a05fe0a2c94
|
69
|
|
Pathological overproduction: the bad side of adenosine, file e309ade2-65f7-3969-e053-3a05fe0a2c94
|
64
|
|
The activation of μ-opioid receptor potentiates LPS-induced NF-kB promoting an inflammatory phenotype in microglia, file e309ade1-1e52-3969-e053-3a05fe0a2c94
|
57
|
|
Role and function of A2A and A3 adenosine receptors in patients with ankylosing spondylitis, psoriatic arthritis and rheumatoid arthritis, file e309ade1-4cf1-3969-e053-3a05fe0a2c94
|
55
|
|
Positive allosteric modulation of A1 adenosine receptors as a novel and promising therapeutic strategy for anxiety, file e309ade3-b282-3969-e053-3a05fe0a2c94
|
52
|
|
The role of adenosine receptors in psychostimulant addiction, file e309ade1-e75e-3969-e053-3a05fe0a2c94
|
48
|
|
Alteration of adenosine receptore in patients with chronic obstructive pulmonary disease, file e309ade4-913f-3969-e053-3a05fe0a2c94
|
43
|
|
A(2B) adenosine receptors stimulate IL-6 production in primary murine microglia through p38 MAPK kinase pathway, file e309ade1-1afc-3969-e053-3a05fe0a2c94
|
37
|
|
Characterization of A2A Adenosine Receptors in Human Lymphocyte Membranes by [3H]-SCH 58261 Binding, file e309ade4-e240-3969-e053-3a05fe0a2c94
|
35
|
|
Synthesis, biological evaluation and docking studies of a novel class of sulfur-bridged diazabicyclo[3.3.1]nonanes, file dde59df4-4fe0-4961-8194-f6c697a38b89
|
28
|
|
Adenosine as a Multi-Signalling Guardian Angel in Human Diseases: When, Where and How Does it Exert its Protective Effects?, file e309ade1-123c-3969-e053-3a05fe0a2c94
|
21
|
|
Cytokine Profiling in Myeloproliferative Neoplasms: Overview on Phenotype Correlation, Outcome Prediction, and Role of Genetic Variants, file e309ade5-1d93-3969-e053-3a05fe0a2c94
|
21
|
|
Adenosine receptors and cancer, file e309ade0-3bd2-3969-e053-3a05fe0a2c94
|
15
|
|
A1 Adenosine Receptor Partial Agonists and Allosteric Modulators: Advancing Toward the Clinic?, file e309ade3-6629-3969-e053-3a05fe0a2c94
|
12
|
|
The Detrimental Action of Adenosine on Glutamate-Induced Cytotoxicity in PC12 Cells Can Be Shifted towards a Neuroprotective Role through A1AR Positive Allosteric Modulation, file e309ade3-0748-3969-e053-3a05fe0a2c94
|
11
|
|
A2A Adenosine Receptor Antagonists in Neurodegenerative Diseases, file 47e1a918-5dec-4787-a9c7-8cdce4bd1e10
|
10
|
|
Alzheimer and purinergic signaling: Just a matter of inflammation?, file e309ade5-0b55-3969-e053-3a05fe0a2c94
|
9
|
|
Pathophysiological Role and Medicinal Chemistry of A2A Adenosine Receptor Antagonists in Alzheimer's Disease, file 45e403cd-91ef-4371-8e90-1b4e18f54711
|
8
|
|
Positive allosteric modulation of A1 adenosine receptors as a novel and promising therapeutic strategy for anxiety, file e309ade1-1c25-3969-e053-3a05fe0a2c94
|
7
|
|
Adenosinergic System Involvement in Ischemic Stroke Patients' Lymphocytes, file e309ade2-ff4f-3969-e053-3a05fe0a2c94
|
7
|
|
An Open Question: Is the A2A Adenosine Receptor a Novel Target for Alzheimer's Disease Treatment?, file e309ade5-092b-3969-e053-3a05fe0a2c94
|
7
|
|
Adenosine Receptors in Neuropsychiatric Disorders: Fine Regulators of Neurotransmission and Potential Therapeutic Targets, file e309ade5-4959-3969-e053-3a05fe0a2c94
|
7
|
|
Medicinal Chemistry, Pharmacology, and Clinical Implications of TRPV1 Receptor Antagonists, file e309ade1-89ac-3969-e053-3a05fe0a2c94
|
6
|
|
A3 Adenosine Receptors as Modulators of Inflammation: From Medicinal Chemistry to Therapy, file e309ade1-fb1d-3969-e053-3a05fe0a2c94
|
6
|
|
A2A Adenosine Receptor as a Potential Biomarker and a Possible Therapeutic Target in Alzheimer's Disease, file e309ade4-eee0-3969-e053-3a05fe0a2c94
|
6
|
|
Potentiating Cancer Immune Therapy via Nanomaterials and Purinergic Signaling, file e309ade5-9042-3969-e053-3a05fe0a2c94
|
6
|
|
A2A Adenosine Receptor: A Possible Therapeutic Target for Alzheimer's Disease by Regulating NLRP3 Inflammasome Activity?, file 78945b54-b81c-49ca-9d9e-5b0e5dad3ec5
|
5
|
|
null, file e309ade1-1910-3969-e053-3a05fe0a2c94
|
5
|
|
Caffeine for Prevention of Alzheimer's Disease: Is the A2A Adenosine Receptor Its Target?, file 009ed723-46c6-4692-8f84-264d88948212
|
4
|
|
Microglia and Alzheimer's Disease, file 6797a60c-2348-42b4-ab89-da5d60c3e7b6
|
4
|
|
Synthesis, Pharmacological Evaluation, and Docking Studies of Novel Pyridazinone-Based Cannabinoid Receptor Type 2 Ligands, file e309ade1-e171-3969-e053-3a05fe0a2c94
|
4
|
|
Deficiency of polycystin-2 reduces Ca2+ channel actvity and cell proliferation in ADPKD lymphoblastoid cells, file e309ade2-81bd-3969-e053-3a05fe0a2c94
|
4
|
|
Targeting A3 and A2A adenosine receptors in the fight against cancer, file e309ade2-8c27-3969-e053-3a05fe0a2c94
|
4
|
|
Biological effects on μ-receptors affinity and selectivity of aryl propenyl chain structural modification on diazatricyclodecane derivatives, file e309ade5-092c-3969-e053-3a05fe0a2c94
|
4
|
|
Water-Soluble Pyrazolo[4,3-e][1,2,4]triazolo[1,5-c]pyrimidines as Human A3 Adenosine Receptor Antagonists, file e309ade0-2fe0-3969-e053-3a05fe0a2c94
|
3
|
|
Deregulation of Adenosine Receptors in Psoriatic Epidermis: An Option for Therapeutic Treatment, file e309ade1-1769-3969-e053-3a05fe0a2c94
|
3
|
|
null, file e309ade1-1772-3969-e053-3a05fe0a2c94
|
3
|
|
Synthesis, molecular modeling and SAR study of novel pyrazolo[5,1-f][1,6]naphthyridines as CB2receptor antagonists/inverse agonists, file e309ade1-1b06-3969-e053-3a05fe0a2c94
|
3
|
|
null, file e309ade1-2d29-3969-e053-3a05fe0a2c94
|
3
|
|
Adenosine Receptors as a Biological Pathway for the Anti-Inflammatory and Beneficial Effects of Low Frequency Low Energy Pulsed Electromagnetic Fields, file e309ade1-4195-3969-e053-3a05fe0a2c94
|
3
|
|
A2B AND A3 ADENOSINE RECEPTORS MODULATE VASCULAR ENDOTHELIAL GROWTH FACTOR AND INTERLEUKIN-8 EXPRESSION IN HUMAN MELANOMA CELLS TREATED WITH ETOPOSIDE AND DOXORUBICIN., file e309ade2-379c-3969-e053-3a05fe0a2c94
|
3
|
|
A2A Adenosine Receptor Antagonists in Neurodegenerative Diseases, file e309ade4-e8d8-3969-e053-3a05fe0a2c94
|
3
|
|
Therapeutic Potential of Allicin and Aged Garlic Extract in Alzheimer's Disease, file 1779e092-7524-4865-9473-6d443ab93774
|
2
|
|
The Effect of Different Storage Conditions on Phytochemical Composition, Shelf-Life, and Bioactive Compounds of Voghiera Garlic PDO, file b737fdc2-e07a-42cb-a6c6-f0d8b43774e7
|
2
|
|
Expression of A3 adenosine receptors in human lymphocytes: up-regulation in T cell activation, file e309ade0-2cc9-3969-e053-3a05fe0a2c94
|
2
|
|
null, file e309ade0-3b24-3969-e053-3a05fe0a2c94
|
2
|
|
A(2A) adenosine receptors are differentially modulated by pharmacological treatments in rheumatoid arthritis patients and
their stimulation ameliorates adjuvant-induced arthritis in rats, file e309ade0-4772-3969-e053-3a05fe0a2c94
|
2
|
|
null, file e309ade1-1d26-3969-e053-3a05fe0a2c94
|
2
|
|
Pulsed Electromagnetic Field Exposure Reduces Hypoxia and Inflammation Damage in Neuron-Like and Microglial Cells, file e309ade1-3fe2-3969-e053-3a05fe0a2c94
|
2
|
|
van't Hoff Based Thermodynamics, file e309ade1-ad62-3969-e053-3a05fe0a2c94
|
2
|
|
Signaling pathways involved in anti-inflammatory effects of Pulsed Electromagnetic Field in microglial cells, file e309ade2-5fc2-3969-e053-3a05fe0a2c94
|
2
|
|
Pulsed electromagnetic field and relief of hypoxia-induced neuronal cell death: The signaling pathway, file e309ade2-666a-3969-e053-3a05fe0a2c94
|
2
|
|
Pulsed Electromagnetic Fields Increased the Anti-Inflammatory Effect of A2A and A3 Adenosine Receptors in Human T/C-28a2 Chondrocytes and hFOB 1.19 Osteoblasts., file e309ade2-c1f7-3969-e053-3a05fe0a2c94
|
2
|
|
Binding thermodynamics at the human cannabinoid CB1 and CB2 receptors, file e309ade2-c698-3969-e053-3a05fe0a2c94
|
2
|
|
“Sistemi di trasmissione: Trasmissione purinergica”,
In “F. Rossi, V. Cuomo, C. Riccardi. Farmacologia. Principi di base e applicazioni
terapeutiche. Edizioni Minerva Medica. IV Edizione, Torino 2020”., file e309ade4-e05c-3969-e053-3a05fe0a2c94
|
2
|
|
Upregulation of Cortical A2Aadenosine receptors is reflected in platelets of patients with Alzheimer's Disease, file e309ade4-fb15-3969-e053-3a05fe0a2c94
|
2
|
|
Strategies for Drug Delivery into the Brain: A Review on Adenosine Receptors Modulation for Central Nervous System Diseases Therapy, file 5d9e8808-8db3-4ecd-9a7f-1f6f3f2fd63f
|
1
|
|
Characterization of adenosine receptors in bovine chondrocytes and
fibroblast-like synoviocytes exposed to low frequency low energy pulsed electromagnetic fields., file e309ade0-21b3-3969-e053-3a05fe0a2c94
|
1
|
|
Pharmacology of [Tyr(1)]nociceptin analogs: receptor binding and bioassay studies, file e309ade0-2303-3969-e053-3a05fe0a2c94
|
1
|
|
null, file e309ade0-2508-3969-e053-3a05fe0a2c94
|
1
|
|
Caffeine inhibits adenosine-induced accumulation of hypoxia-inducible factor-1α, vascular endothelial growth factor, and interleukin-8 expression in hypoxic human colon cancer cells, file e309ade0-25de-3969-e053-3a05fe0a2c94
|
1
|
|
Pharmacological characterization of P2X1 and P2X3 purinergic receptors in bovine chondrocytes., file e309ade0-2871-3969-e053-3a05fe0a2c94
|
1
|
|
Alteration of adenosine receptors in patients with chronic obstructive pulmonary disease, file e309ade0-2deb-3969-e053-3a05fe0a2c94
|
1
|
|
Deficiency of polycystin-2 reduces Ca2+ channel activity and cell proliferation in ADPKD lymphoblastoid cells, file e309ade0-2f0d-3969-e053-3a05fe0a2c94
|
1
|
|
null, file e309ade0-3204-3969-e053-3a05fe0a2c94
|
1
|
|
A1 and A3 adenosine receptors inhibit LPS-induced hypoxia-inducible factor-1 accumulation in murine astrocytes, file e309ade0-4318-3969-e053-3a05fe0a2c94
|
1
|
|
Biochemical and pharmacological role of A1adenosine receptors and their modulation as novel therapeutic strategy, file e309ade2-745d-3969-e053-3a05fe0a2c94
|
1
|
|
Synthesis, biological evaluation and docking studies of a novel class of sulfur-bridged diazabicyclo[3.3.1]nonanes, file e309ade2-d6ce-3969-e053-3a05fe0a2c94
|
1
|
|
Adenosine receptors in health and disease, file e309ade5-5cdb-3969-e053-3a05fe0a2c94
|
1
|
| Totale |
2.984 |